Zhou, H., Wang, Y., Lin, Y., Cai, W., Li, X., & He, X. (2021). Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Zhou, Hong, Yuehui Wang, Yanfang Lin, Wenjie Cai, Xiaofeng Li, y Xiaomeng He. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Zhou, Hong, et al. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A, 2021.